B&K acquisition is a strategic fit for 360ONE as it will enhance its business in multiple ways: it will provide equity advisory to existing clients; corporate advisory of B&K will benefit from the product portfolio of 360ONE; and the corporate relationships of 360ONE will help to scale up the international business business. The deal is likely to be EPS-accretive by 3-5%.
NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Motilal Oswal Report
360ONE Wam Ltd. maintains a strong position in the industry, reflected by robust flows and consistent performance. Diversification across client segments (mass affluent) and geography (lower-tier cities) is gaining traction, and its global platform has also seen green shoots.
The B&K acquisition will bring in many synergies and is expected to be 3-5% EPS-accretive.
We have cut our estimates by 2%/4% for FY26/FY27 to factor in the mark-to-market hit along with lower assumptions on growth in inflows.
We have not yet built in revenues/costs/dilution for the B&K acquisition. We retain our Buy rating with a one-year target price of Rs 1,250, premised on 34 times FY27E earnings per share.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
RECOMMENDED FOR YOU
JSW Steel-JFE Steel JV On BPSL Spurs Growth; Motilal Oswal Reiterates 'Buy' Call
'Buy' HPCL Shares Maintains Motilal Oswal, Sees Upto 31% Upside — Check Target Price
Ambuja Cements Can Zoom Upto 38% On Scale And Synergy Play, Says Motilal Oswal Maintaining 'Buy'
Cohance Lifesciences Q2 Review — ICICI Securities Slashes Target Price By 49%; Downgrades Stock To 'Reduce'
POPULAR